First Page | Document Content | |
---|---|---|
Date: 2005-10-26 17:35:48Lactones Oxandrolone Savient Pharmaceuticals United States Pharmacopeia Food and Drug Administration Monograph Drug reference standard USP Abbreviated New Drug Application Pharmacology Pharmaceutical sciences Publishing | LAW OFFICES HYMAN,PHELPS 6 MCNAMARA,Add to Reading ListSource URL: www.fda.govDownload Document from Source WebsiteFile Size: 175,32 KBShare Document on Facebook |
Microsoft Word - Savient Phase 3 Dosing press releasedocDocID: 1ri7E - View Document | |
Microsoft Word - Savient press release re ACRdocDocID: 1reUR - View Document | |
Microsoft Word - Savient press release Puricase SPAdocDocID: 1qW9f - View Document | |
Microsoft Word - puricase-Phase I-ivpress release.docDocID: 1qOjy - View Document | |
Microsoft Word - Savient Reports Positive Top-Line ResultsdocDocID: 1qCIQ - View Document |